FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for difluprednate ophthalmic from Sandoz, updating labeling (new indication or labeling changes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation of the Eye
• Postoperative Inflammation of the Eye

Drugs mentioned

• Difluprednate ophthalmic (Difluprednate)

Snippet

SUPPL AP for DIFLUPREDNATE OPHTHALMIC (DIFLUPREDNATE OPHTHALMIC)